NeoGenomics Laboratories, Inc. (NEO): financial analysis & fundamentals
Health Care · price $18.64 · market cap —
In short — NeoGenomics Laboratories, Inc. trades at —× earnings (P/E), —× expected earnings, for a PEG of — and a net margin of —. Revenue growth —. Quick verdict: valuation to review.
Is NeoGenomics Laboratories, Inc. stock expensive?
NeoGenomics Laboratories, Inc. has a P/E of — (forward P/E —) and a PEG of —. A PEG below 1 is rather cheap given growth, above 2 is expensive. Verdict: valuation to review.
What is NeoGenomics Laboratories, Inc.'s net margin?
NeoGenomics Laboratories, Inc.'s net margin is about — — the share of revenue that ends up as net profit.
What is NeoGenomics Laboratories, Inc.'s revenue?
NeoGenomics Laboratories, Inc.'s income statement is detailed on this page.
What is NeoGenomics Laboratories, Inc.'s market cap?
NeoGenomics Laboratories, Inc. (NEO) has a market cap of about —.
Does NeoGenomics Laboratories, Inc. pay a dividend?
No, NeoGenomics Laboratories, Inc. does not currently pay a dividend (it reinvests earnings).
What is JPI Invest?
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
💬 AI assistant: ask anything about any stock, with the numbers